BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7303557)

  • 1. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
    Shenderëva TS; Shvedova LA
    Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
    Bokhman IaV; Volkova AT; Chepik OF; Vishnevskiĭ AS
    Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].
    Bochmann JW
    Zentralbl Gynakol; 1981; 103(21):1289-93. PubMed ID: 7324631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal therapy of cancer of the corpus uteri].
    Nigaĭ SV; Smakhtina OL; Kozbagarova RG; Nigmatullina AA
    Vopr Onkol; 1983; 29(3):22-6. PubMed ID: 6836982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined morphologic evaluation of the efficacy of progestin therapy of primary endometrial cancer].
    Shvedova LA; Botnar' ER; Shendereva TS; Volostnykh LV; Chernyĭ AP
    Vopr Onkol; 1984; 30(3):40-4. PubMed ID: 6710947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of hydroxyprogesterone caproate and its combination with tamoxifen on steroid hormone receptors in the tumor and on the basic parameters of reproductive homeostasis in patients with cancer of the corpus uteri].
    Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Shtofmakher IA
    Vopr Onkol; 1989; 35(9):1063-7. PubMed ID: 2815695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1985 Feb; 20(2):139-55. PubMed ID: 3972284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of 17-alpha-hydroxprogesterone-capronate in certain malignant tumors].
    Garin AM; Voznyĭ EK; Borisov VI; Dobrushina VA; Lazovskaia EB
    Klin Med (Mosk); 1974 Mar; 52(3):121-3. PubMed ID: 4466932
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
    Onsrud M
    Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of total regression of endometrial carcinoma metastases in the lung under hormonal therapy (author's transl)].
    Caminati M; Hauser GA
    Ther Umsch; 1979 Jun; 36(6):516-7. PubMed ID: 462406
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of hormone therapy in the treatment of cancer of the endometrium].
    Vekhova LI; Shuvaeva NI; Malysheva SF; Lebedeva AV
    Vopr Onkol; 1983; 29(3):26-30. PubMed ID: 6836983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic progestins in combined treatment of cancer of the uterine body].
    Iatskovskai NL
    Vopr Onkol; 1976; 22(3):25-8. PubMed ID: 936523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
    [No Abstract]   [Full Text] [Related]  

  • 14. [Central mechanism of the action of 17-alpha-hydroxy-progesterone capronate in the treatment of endometrial cancer].
    Krylova NV; Bokhman IaV; Chepik OF; Dil'man VM
    Akush Ginekol (Mosk); 1977 Sep; (9):50-3. PubMed ID: 596564
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of progestational agents in treatment of endometrial carcinoma.
    Podratz KC; O'Brien PC; Malkasian GD; Decker DG; Jefferies JA; Edmonson JH
    Obstet Gynecol; 1985 Jul; 66(1):106-10. PubMed ID: 4011061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is a cure possible for primary state-I endometrial cancer using drug therapy?].
    Bokhman IaV; Chepik OF; Volkova AT; Vishnevskiĭ AS
    Vopr Onkol; 1982; 28(3):34-42. PubMed ID: 7064417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of 19-nor-17 alpha-hydroxyprogesterone caproate in endometrial cancer].
    Márquez J; Dabancens A; González O; Rosmanich A
    Rev Chil Obstet Ginecol; 1976; 41(5):304-11. PubMed ID: 1030512
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
    Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Fel'dkoren BI
    Vopr Onkol; 1989; 35(5):594-8. PubMed ID: 2545046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.
    Reifenstein EC
    Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial of adjuvant progestagen in early endometrial cancer.
    Vergote I; Kjørstad K; Abeler V; Kolstad P
    Cancer; 1989 Sep; 64(5):1011-6. PubMed ID: 2667746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.